These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8215580)

  • 41. [Dexamethasone in the treatment of bronchopulmonary dysplasia].
    Schrod L; Frauendienst-Egger G; Forgber I; von Stockhausen HB
    Pneumologie; 1991 Nov; 45(11):892-6. PubMed ID: 1762998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lower gastrointestinal tract perforation in preterm infants treated with dexamethasone for bronchopulmonary dysplasia.
    Ng PC; Fok TF; So KW; Wong W; Yip PK; Liu K
    Pediatr Surg Int; 1997 Feb; 12(2-3):211-2. PubMed ID: 9156866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dexamethasone therapy for bronchopulmonary dysplasia.
    Kramer LI
    Va Med Q; 1994; 121(4):239-40, 244. PubMed ID: 7948077
    [No Abstract]   [Full Text] [Related]  

  • 44. Dexamethasone for bronchopulmonary dysplasia.
    Donn SM; Faix RG; Banagale RC
    Lancet; 1983 Aug; 2(8347):460. PubMed ID: 6135948
    [No Abstract]   [Full Text] [Related]  

  • 45. Response to dexamethasone in ventilated preterm infants: effect of radiographic subtype of chronic lung disease.
    Kothadia JM; O'Shea TM; Auringer ST; Dillard RG
    Am J Perinatol; 1996 Aug; 13(6):377-81. PubMed ID: 8865986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dexamethasone and bronchopulmonary dysplasia.
    Frank L; Lecuona PC
    Pediatrics; 1996 Sep; 98(3 Pt 1):514-5. PubMed ID: 8784386
    [No Abstract]   [Full Text] [Related]  

  • 47. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone.
    Ballabh P; Simm M; Kumari J; Califano C; Aghai Z; Laborada G; Sison C; Cunningham-Rundles S
    Pediatr Pulmonol; 2003 May; 35(5):392-9. PubMed ID: 12687597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dexamethasone therapy in severe bronchopulmonary dysplasia.
    Bourchier D
    Aust Paediatr J; 1988 Feb; 24(1):41-4. PubMed ID: 3355444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation.
    Kazzi NJ; Brans YW; Poland RL
    Pediatrics; 1990 Nov; 86(5):722-7. PubMed ID: 2235226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dexamethasone therapy in preterm infants developing bronchopulmonary dysplasia: effect on pulmonary surfactant disaturated-phosphatidylcholine kinetics.
    Cogo PE; Simonato M; Mariatoffolo G; Stefanutti G; Chierici M; Cobelli C; Ori C; Carnielli VP
    Pediatr Res; 2008 Apr; 63(4):433-7. PubMed ID: 18356753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies.
    Papagianis PC; Pillow JJ; Moss TJ
    Paediatr Respir Rev; 2019 Apr; 30():34-41. PubMed ID: 30201135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurological adverse effects of early postnatal dexamethasone in very preterm infants.
    Baud O; Zupan V; Lacaze-Masmonteil T; Dehan M
    Arch Dis Child Fetal Neonatal Ed; 1999 Mar; 80(2):F159. PubMed ID: 10325800
    [No Abstract]   [Full Text] [Related]  

  • 53. Catabolic effect of dexamethasone in the preterm baby.
    Brownlee KG; Ng PC; Henderson MJ; Smith M; Green JH; Dear PR
    Arch Dis Child; 1992 Jan; 67(1 Spec No):1-4. PubMed ID: 1482427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Steroids, chronic lung disease, and retinopathy of prematurity.
    Ehrenkranz RA
    Pediatrics; 1992 Oct; 90(4):646-7. PubMed ID: 1408525
    [No Abstract]   [Full Text] [Related]  

  • 55. Basal and post-ACTH cortisol levels in preterm infants following treatment with dexamethasone.
    Cronin CM; Dean H; MacDonald NT; Seshia MM
    Clin Invest Med; 1993 Feb; 16(1):8-14. PubMed ID: 8385590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Neonatology; 2010; 98(3):217-24. PubMed ID: 20389126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Corticotherapy: too dangerous a treatment for bronchopulmonary dysplasia?].
    Walti H; Moriette G; de Ajuriaguerra M; de Gamarra E; Relier JP
    Ann Pediatr (Paris); 1986 Jan; 33(1):29-32. PubMed ID: 3963699
    [No Abstract]   [Full Text] [Related]  

  • 58. High-mobility group box-1 protein in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia and steroid therapy.
    Aghai ZH; Saslow JG; Meniru C; Porter C; Eydelman R; Bhat V; Stahl G; Sannoh S; Pyon K; Hewitt C; Bhandari V
    J Perinatol; 2010 Sep; 30(9):610-5. PubMed ID: 20182437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postnatal steroids: the way forward.
    Halliday HL
    Arch Dis Child Fetal Neonatal Ed; 2011 May; 96(3):F158-9. PubMed ID: 21289014
    [No Abstract]   [Full Text] [Related]  

  • 60. Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications.
    Noble-Jamieson CM; Regev R; Silverman M
    Eur J Pediatr; 1989 Jan; 148(4):365-7. PubMed ID: 2651132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.